Influence of Exercise on Anemia in MDS Patients

This study has been withdrawn prior to enrollment.
(We were unable to find patients that fit the eligibility criteria.)
Sponsor:
Information provided by (Responsible Party):
University of Rochester
ClinicalTrials.gov Identifier:
NCT01783249
First received: November 30, 2011
Last updated: January 31, 2013
Last verified: January 2013
  Purpose

That exercise will reduce anemia and fatigue, while improving aerobic capacity, strength and hematopoietic stem and progenitor cell mitochondrial function.


Condition Intervention Phase
Feasibility Pilot Study
Other: Stationary Exercise cycling
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: The Influence of Exercise on Anemia in MDS Patients

Resource links provided by NLM:


Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • Feasibility data on the effect of a stationary cycling program [ Designated as safety issue: Yes ]
    Aim to provide preliminary feasibility data on the effect of a stationary cycling program on anemia and acrocytosis, fatigue, aerobic capacity, strength, and hematopoietic stem and progenitor cell mitochondrial function in MDS patients.


Enrollment: 0
Study Start Date: November 2011
Study Completion Date: November 2012
Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Usual care monitoring
Exercise using stationary cycling
Stationary cycling exercise program
Other: Stationary Exercise cycling
Stationary exercise cycling

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:Have a confirmed diagnosis of MDS, Have approval of the study medical monitor, be able to read English, be 21 years of age or older, give informed consent -

Exclusion Criteria: Have physical limitations, be identified in the active or maintenance stage of exercise behavior

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01783249

Locations
United States, New York
James P. Wilmot Cancer Center, University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
  More Information

No publications provided

Responsible Party: University of Rochester
ClinicalTrials.gov Identifier: NCT01783249     History of Changes
Other Study ID Numbers: 37173MDS
Study First Received: November 30, 2011
Last Updated: January 31, 2013
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on October 20, 2014